CLARISCAN Solution for Injection

Gadoteric acid

0.5 mmol/ml

GE HEALTHCARE AS

Pack size	10 Pre-filled Syringe (10 ml)
Dispensing mode
Source
Agent
Retail Price	71.41 AED

Available as:

0.5 mmol/ml - Solution for Injection in Pre-filled Syringe 0.5 mmol/ml - Ointment 0.5 mmol/ml - Solution 0.5 mmol/ml - Solution for Injection 0.5 mmol/ml - Solution for Injection

Indications

CLARISCAN Solution for Injection is used for: Gadoteric acid is indicated for intravenous use with magnetic resonance imaging (mri) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (bbb) and/or abnormal vascularity

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Gadoteric acid :

Mechanism of Action

Gadoterate is a paramagnetic molecule that develops a magnetic moment when placed in a magnetic field. The magnetic moment enhances the relaxation rates of water protons in its vicinity, leading to an increase in signal intensity (brightness) of tissues. When placed in a magnetic field, gadoterate shortens the t1 and t2 relaxation times in target tissues

Note

CLARISCAN 0.5 mmol/ml Solution for Injection manufactured by GE HEALTHCARE AS. Its generic name is Gadoteric acid. CLARISCAN is availble in Saudi Arabia. Farmaco SA drug index information on CLARISCAN Solution for Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Gadoteric acid :

Suspension for Injection in Pre-filled Syringe

DOTAREM ^{376 mmol/ml}

BAYER SCHERING PHARMA AG

Suspension for Injection in Pre-filled Syringe

DOTAREM ^{376 mmol/ml}

BAYER SCHERING PHARMA AG

Solution

DOTAREM ^{27.932 g}

BAYER SCHERING PHARMA AG

Solution for Injection in Pre-filled Syringe

CLARISCAN ^{0.5 mmol/ml}

GE HEALTHCARE AS

Ointment

CLARISCAN ^{0.5 mmol/ml}

GE HEALTHCARE AS